Latest Breaking News On - Biotechnology trading down - Page 2 : comparemela.com

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Down 18 6% in March

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Down 18 6% in March
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesMaximof nouguesAlanh auerbachMackenzie financial corpPuma biotechnology incPuma biotechnology company profileBalyasny asset managementPuma biotechnologyGet free reportStreet groupAsset managementFinancial corpBiotechnology trading downPuma biotechnology daily

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Update

Puma Biotechnology, Inc (NASDAQ:PBYI) Short Interest Update
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh auerbachMaximof nouguesSecurities exchange commissionMackenzie financial corpBalyasny asset managementPuma biotechnology incPuma biotechnologyGet free reportExchange commissionStreet groupAsset managementFinancial corpBiotechnology trading downPuma biotechnology daily

Nautilus Biotechnology (NAUT) to Release Quarterly Earnings on Wednesday

Nautilus Biotechnology (NAUT) to Release Quarterly Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nautilus biotechnology company profilePrelude capital managementNautilus biotechnology incCitigroup incShay capitalNautilus biotechnologyGet free reportBiotechnology trading downCapital managementNautilus platformNautilus biotechnology daily

Vir Biotechnology (NASDAQ:VIR) Shares Down 2 7% After Insider Selling

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price was down 2.7% on Tuesday after an insider sold shares in the company. The stock traded as low as $11.42 and last traded at $11.58. Approximately 140,465 shares changed hands during trading, a decline of 87% from the average daily volume of 1,121,850 shares. The […]

Georgea scangosJpmorgan chase coBarclays plcVanguard group incSecurities exchange commissionNeedham companyVoloridge investment managementVir biotechnology incNuveen asset managementVir biotechnologyGet free reportExchange commissionDirector georgeBiotechnology trading downInvestment managementAsset management

Vir Biotechnology (NASDAQ:VIR) Price Target Cut to $85 00

Vir Biotechnology (NASDAQ:VIR – Free Report) had its price objective trimmed by HC Wainwright from $95.00 to $85.00 in a research report report published on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Vir Biotechnology’s Q1 2024 earnings at ($0.99) EPS, Q2 2024 […]

Needham companyCm bidwell associates ltdVir biotechnology incFifth third bancorpVir biotechnology company profileThird bancorpChina universal asset management coVir biotechnologyFree reportModerate buyBiotechnology trading downGet free reportUniversal asset managementFinancial advisorsQuantbot technologiesVir biotechnology daily